IMPAACT P1085: Human Papilloma Virus (HPV) Type-Specific Antibody

This study has been completed.
National Institute of Allergy and Infectious Diseases (NIAID)
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Merck Sharp & Dohme Corp.
Information provided by (Responsible Party):
International Maternal Pediatric Adolescent AIDS Clinical Trials Group Identifier:
First received: September 20, 2010
Last updated: March 30, 2015
Last verified: March 2015
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: August 2013
  Primary Completion Date: December 2012 (Final data collection date for primary outcome measure)